Hilary Weingarden, PhD is an Assistant Professor at Harvard Medical School and a psychologist in the Center for OCD and Related Disorders (CORD) at Massachusetts General Hospital (MGH). Her current research focuses on cognitive and emotional risk factors for adverse outcomes in individuals with OCD and body dysmorphic disorder (BDD). She is also interested in applying technology to enhance assessment of and interventions for OCD and related disorders.
-
As the demand for psychotherapy far exceeds the availability of clinicians, the Perspectives smartphone app offers a scalable, accessible solution for the treatment of body […] -
As the demand for psychotherapy far exceeds the availability of clinicians, the Perspectives smartphone app offers a scalable, accessible solution for the treatment of BDD. -
Greater motivation and readiness to change and greater treatment expectancy were predictors of treatment response. -
In total, 52% of the CBT group and 27% of the SPT group experienced a sustained remission of their symptoms at six months.